Yousuf M Khalifa, Seth M Pantanelli. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AgedAngiogenesis Inhibitors/administration & dosageAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal, HumanizedBevacizumabCataract/etiologyCataract ExtractionEye Injuries, Penetrating/diagnosisEye Injuries, Penetrating/etiologyHumansIntravitreal InjectionsMacular Degeneration/drug therapyMaleNeedlestick Injuries/complicationsNeedlestick Injuries/diagnosisPosterior Capsule of the Lens/injuriesPosterior Capsule of the Lens/pathologyVascular Endothelial Growth Factor A/antagonists & inhibitorsWound Healing
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2011 PMID： 21700115 DOI： 10.1016/j.jcrs.2011.04.016
Source DB: PubMed Journal: J Cataract Refract Surg ISSN： 0886-3350 Impact factor: 3.351